A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer

Clinical Trial ID NCT00670189

Rank	Title	Journal	Year	PubWeight™‹?›
1	G protein-coupled receptors: novel targets for drug discovery in cancer.	Nat Rev Drug Discov	2011	3.31
2	Unraveling the therapeutic potential of the Hedgehog pathway in cancer.	Nat Med	2013	2.55
3	Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.	Nat Rev Clin Oncol	2015	2.02
4	Emerging targeted agents in metastatic breast cancer.	Nat Rev Clin Oncol	2013	1.59
5	Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.	J Oncol	2010	1.40
6	Hedgehog-Gli signaling pathway inhibitors as anticancer agents.	J Med Chem	2009	1.14
7	Targeting cancer stem cells: a new therapy to cure cancer patients.	Am J Cancer Res	2012	1.11
8	Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.	Expert Rev Mol Med	2015	0.87
9	Can nanomedicines kill cancer stem cells?	Adv Drug Deliv Rev	2013	0.86
10	Therapeutics formulated to target cancer stem cells: Is it in our future?	Cancer Cell Int	2011	0.83
11	Hedgehog signaling pathway in ovarian cancer.	Int J Mol Sci	2013	0.82
12	Therapeutic approaches to target cancer stem cells.	Cancers (Basel)	2011	0.80
13	Novel investigational drugs for basal cell carcinoma.	Expert Opin Investig Drugs	2010	0.78
14	Targeted therapy in nonmelanoma skin cancers.	Cancers (Basel)	2011	0.75
15	Targeting the perpetrator: breast cancer stem cell therapeutics.	Curr Drug Targets	2010	0.75